Endocrinologist Katerina Saltiki, MD, PhD, (a graduate of the School of Medicine, the School of Pharmacy, and a PhD graduate of the Athens Medical School, National and Kapodistrian University of Athens) has served as Head of Clinical and Scientific Affairs at the Thyroid Neoplasms Clinic in the Department of Internal Medicine at the National and Kapodistrian University of Athens. She continues to serve as a Special Scientific Associate at the Therapeutic Clinic (for thyroid neoplasms and related genetic syndromes) and at the Clinical & Translational Research Unit in Endocrinology, National and Kapodistrian University of Athens.”
He has an extensive teaching record, focusing primarily on thyroid neoplasms, for undergraduate and graduate students, residents, and board-certified endocrinologists (who have been trained at the Neoplasm Clinic in the Department of Internal Medicine). He has also conducted significant research. He is the author of more than 45 chapters in medical textbooks, more than 45 publications in international medical journals with high impact factors, and more than 180 medical presentations at international and national conferences. She has received more than ten pan-European and national awards for her scientific work. She is a member of the ESE (European Society of Endocrinology), ETA (European Thyroid Association), and HES (Hellenic Endocrine Society). Email: saze@otenet.gr
PUBLICATIONS IN FOREIGN JOURNALS:
- SALTIKI K, DOUKAS CH, KANAKAKIS J, ANASTASIOU E, MANTZOU E, ALEVIZAKI M.
Severity of cardiovascular disease in women: relationship with exposure to endogenous estrogen.
Maturitas, 2006;55:51-57.
- ALEVIZAKI M, SALTIKI K, MANTZOU E, ANASTASIOU E, HUHTANIEMI I.
The adrenal gland may be a target of LH action in postmenopausal women.
Eur J Endocrinol, 2006;154:875-881.
- SALTIKI, K., ALEVIZAKI, M.
Coronary heart disease in postmenopausal women; The role of endogenous estrogens and their receptors.
Hormones, 2007;6:9-24.
- ALEVIZAKI M, SALTIKI K, XITA N, KANAKAKIS I, MANTZOU E, GEORGIOU I, SARIKA H-L.
Severity of Cardiovascular Disease in Women: Associations with Common Polymorphic Variants of the Estrogen Receptor Alpha.
Eur J Endocrinol, 2007;56:489-496.
- ALEVIZAKI M, SALTIKI K, XITA N, CIMPONERIU A, STAMATELOPOULOS K, MANTZOU E, DOUKAS C, GEORGIOU I.
Menopause, 2008;15:461-8.
- SALTIKI K, VOIDONIKOLA P, STAMATELOPOULOS K, MANTZOU E, PAPAMICHAEL C, ALEVIZAKI M.
Thyroid Res, September 29, 2008; 1(1):3.
- SALTIKI K, CIMPONERIU A, LILI K, PEPPA M, ANASTASIOU E, ALEVIZAKI M.
Severity of Coronary Artery Disease in Postmenopausal Women with Diabetes.
Hormones (Athens), 2008;7:148-155.
- ALEVIZAKI, M., MANTZOU, E., CIMPONERIU, A., SALTIKI, K., PHILIPPOU, G., WIERSINGA, W.
Clin Endocrinol, 2009;70:464-8.
- SALTIKI K, MANTZOU E, DOUKAS C, KANAKAKIS I, LAZAROS L, GEORGIOU I, ALEVIZAKI M.
Variants in the Estrogen Receptor Beta Gene May Be Associated with a More Favorable Metabolic Profile in Postmenopausal Women Undergoing Coronary Angiography.
Exp Clin Endocrinol Diabetes, 2009;117:610-615.
- DOUPIS J, STAVRIANOS CH, SALTIKI K, MANTZOU E, MASTROKOSTOPOULOS A, ALEVIZAKI M.
Thyroid volume, selenium levels, and dietary habits among outpatients in southwestern Albania.
Hormones (Athens), 2009;8:296-302.
- ALEVIZAKI M, PAPAGEORGIOU G, RENTZIOU I, SALTIKI K, MARAFELIA P, LOUKARI E, KOUTRAS DA, DIMOPOULOS MA.
The prevalence of papillary thyroid carcinoma has been increasing in Greece in recent years: the majority of cases are incidental.
Thyroid, 2009;19:749-54.
- ALEVIZAKI M, SALTIKI K, STAMATELOPOULOS K, VOIDONIKOLA P, MANTZOU E, PAPAMICHAEL CH.
Free thyroxine is an independent predictor of subcutaneous fat in euthyroid individuals.
Eur J Endocrinol, 2009;161:459-65.
- Terzidis K, Panoutsopoulos A, Mantzou A, Tourli P, Papageorgiou G, Saltiki K, Mara C, Alevizaki M.
Lower early-morning plasma cortisol levels are associated with thyroid autoimmunity in the elderly
Eur J Endocrinol, 2010;162:307-13.
- K. Saltiki, G. Papageorgiou, P. Voidonikola, E. Mantzou, K. Xiromeritis, C. Papamichael, M. Alevizaki, K. Stamatelopoulos.
Endogenous estrogen levels are associated with endothelial function in men, independent of lipid levels
Endocrine, 2010;37:329-335.
- Terzidis K, Panoutsopoulos A, Mantzou A, Tourli P, Papageorgiou G, Saltiki K, Tsagalis G, Mara C, Alevizaki M.
Cortisol Levels and Metabolic Parameters in Middle- and Advanced-Age Subjects: Associations with Age
Journal of Endocrinological Investigation 2011;34:398-402
- Katerina Saltiki, Adriana Cimponeriu, Maria Garofalaki, Lida Sarika, Alexandra Papathoma, Kimon Stamatelopoulos, Maria Alevizaki
Severity of coronary artery disease in women: association with the CAG(n) repeat polymorphism in the androgen receptor gene
Menopause 2011;18:1225-31
- ANASTASIOU E, VASILEIOY V, ATHANASIADOU A, STAVRIANOS C, SALTIKI K, ALEVIZAKI M
Phenotypic and Metabolic Characteristics of Women with Isolated Hyperglycemia During Pregnancy. Does the Time Point Matter?
Diabetes Research and Clinical Practice, 2010; 90:333-8
- Tzanela M, Mantzou E, Saltiki K, Tampourlou M, Kalogeris N, Hadjidakis D, Tsagarakis S, Alevizaki M
Clinical and Biochemical Impact of the BCL1 Polymorphic Genotype of the Glucocorticoid Receptor Gene in Patients with Adrenal Incidentalomas.
Journal of Endocrinological Investigation 2012;35:395-400
- Pappa T, Vemmos K, Saltiki K, Mantzou E, Stamatelopoulos K, Alevizaki M
DHEAS: A Biomarker of Stroke Severity and Functional Outcome in a Female Population Experiencing an Acute Stroke?
Metabolism 2012;61:84-91
- K. Saltiki, K. Stamatelopoulos, P. Voidonikola, L. Lazaros, E. Mantzou, I. Georgiou, E. Anastasiou, C. Papamichael, M. Alevizaki
Association of the SHBG Gene Promoter Polymorphism with Early Markers of Atherosclerosis in Apparently Healthy Women
Atherosclerosis 2011;219:205-10.
- H. Doukas, K. Saltiki, K. Terzidis, A. Mantzou, L. Sarika, A. Cimponeriu, P. Sfikakis, M. Alevizaki
Hormonal Parameters and Sex Hormone Receptor Gene Polymorphisms in Males with Autoimmune Diseases
Rheumatol Int. 2013;33:575-82
- ALEVIZAKI, M., SALTIKI, K., RENTZIOU, G., PAPATHOMA, A., SARIKA, L., VASILEIOU, V., ANASTASIOU, E.
Medullary thyroid carcinoma: the impact of policy changes on
clinical characteristics and disease progression.
Eur J Endocrinol. 2012;167:799-808.
- ALEVIZAKI M, KYRATZOGLOU E, BAMIAS A, TZANELA M, DIMOPOULOS MA, SALTIKI K.
Metachronous occurrence of secondary malignancies in patients with medullary thyroid carcinoma (MTC): a diagnostic challenge and brief review of the literature.
Endocrine. 2013;44:610-5
- RENTZIOU G, SALTIKI K, MANIOS E, STAMATELOPOULOS K, KOROBOKI E, VEMMOU A, MANTZOU E, ZAKOPOULOS N, ALEVIZAKI M.
Effects of recombinant human thyrotropin administration on 24-hour arterial blood pressure in women undergoing evaluation for differentiated thyroid cancer. Int J Endocrinol. 2014;2014:270213.
- SALTIKI K, RENTZIOU G, STAMATELOPOULOS K, GEORGIOPOULOS G, STAVRIANOS C, LAMBRINOUDAKI E, ALEVIZAKI M.
Small medullary thyroid carcinoma: Postoperative calcitonin, rather than tumor size, predicts disease persistence and progression.
Eur J Endocrinol. 2014;17:117-26.
- GYFTAKI R, LIACOS C, POLITI E, LIONTOS M, SALTIKI K, PAPAGEORGIOU T, THOMAKOS N,HAIDOPOULOS D, RODOLAKIS A, ALEVIZAKI M,BAMIAS A, DIMOPOULOS MA
Differential transcriptional and protein expression of thyroid-stimulating
hormone receptor in ovarian carcinomas.
Int J Gynecol Cancer. 2014;24:851-6
27. ALEVIZAKI, M., and SALTIKI, K. Primary hyperparathyroidism in MEN2 syndromes.
Recent Results in Cancer Research. 2015;204:179-86
28. SARIKA HL, PAPATHOMA A, GAROFALAKI M, SALTIKI K, PAPPA T, PAZAITOU-PANAYIOTOU K, ANASTASIOU E, ALEVIZAKI M.
Genetic screening of patients with medullary thyroid cancer at a referral center in Greece over the past two decades.
Eur J Endocrinol. 2015;172:501-9
29. K. SALTIKI, L. SPANOU, M. ALEVIZAKI .“The Utility of Fine Needle Aspiration in the Management of Thyroid Nodules.” HellenicJournal of Surgery, SPRINGER. 2015;87:14-17 30. GIANNAKOU M, SALTIKI K, MANTZOU E, LOUKARI E, PHILIPPOU G, TERZIDIS K, LILI K, STAVRIANOS C, KYPRIANOU M, ALEVIZAKIM. RAGE polymorphisms and oxidative stress levelsin Hashimoto’s thyroiditis.Eur J Clin Invest. 2017;47:341-347 31. SALTIKI KATERINA, SIMEAKIS GEORGE, ANAGNOSTOU ELLI, ZAPANTI EVANGELIA, ANASTASIOU ELENI, ALEVIZAKI MARIA: Worse outcome in sporadic compared to familial medullary thyroid cancer despite similar stage at diagnosis. Head and Neck, 2019;41:154-161 32. KATERINA SALTIKI, ELLI ANAGNOSTOU, GEORGE SIMEAKIS, SOFIA KOUKI, ANASTASIA ANGELOPOULOU, LEDA SARIKA, ALEXANDRA PAPATHOMA, MARIAALEVIZAKI Familial MTC with RET exon 8 GLY533CYS mutation: origin and prevalence of second malignancy EndocrineConnections 2017; 6:676-684 33. MARIA GIANNAKOU; KATERINA SALTIKI; EMILY MANTZOU; ELENI LOUKARI; GEORGIOS PHILIPPOU; KONSTANTINOS TERZIDIS; CHARALAMPOS STAVRIANOS; MILTIADES KYPRIANOU; THEODORA PSALTOPOULOU; MARIA ALEVIZAKI The Effect of Obesity and Dietary Habits on Oxidative Stress in Hashimoto’s Thyroiditis EndocrineConnections 2018; 7:990-997
- OLGA KARAPANOU AND KATERINA SALTIKI, GEORGE SIMEAKIS, EFTHIMIA BOTOULA, STYLIANOS TSAGARAKIS, MARIA ALEVIZAKI, AND BARBARA VLASSOPOULOU
Histological features are more important than persistently elevated anti-Tg antibodies in determining the course of the disease in patients with differentiated thyroid cancer (DTC)
Clinical Endocrinology (Oxf). 2021;95:217-223
- P. KAZAKOU, G. SIMEAKIS, M. ALEVIZAKI, K. SALTIKI
Unusual Metastatic Sites of Medullary Thyroid Carcinoma: Case Reports
Endocrinol Diabetes Metab Case Rep. 2021:21-0063
- KATERINASALTIKI1, GEORGESIMEAKIS2* / OLGAKARAPANOU2*, STAVROULA A.PASCHOU1, MARIAALEVIZAKI1
Metastatic medullary thyroid carcinoma (MTC): disease course, treatment modalities, and factors predisposing to drug resistance
Endocrine. June 2023;80(3):570-579. doi: 10.1007/s12020-022-03296-1. Published online Jan. 10, 2023. PMID: 36626081.
- KARAPANOU, O., SIMEAKIS, G., VLASSOPOULOU, B., ALEVIZAKI, M., SALTIKI, K.
Advanced RAI-refractory thyroid cancer: an update on treatment options.
Endocr Relat Cancer. April 22, 2022;29(5):R57-R66. doi: 10.1530/ERC-22-0006. PMID: 35266878.
- KATERINA SALTIKI, GEORGE SIMEAKIS, OLGA KARAPANOU, MARIA ALEVIZAKI
Eur J Endocrinol. 2022;187: R53-R63.
- KANTREVA K, PASCHOU SA, STEFANAKI K, PAPPA K, KAZAKOU P, VRACHNIS D, KAVOURA E, PAVLAKIS K, GIOVANNOPOULOU E, LATHOURAS K, ALEVIZAKI M, SALTIKI K.
Two rare cases of benign ovarian struma with malignant recurrence. Endocrinology and Diabetes
Metab Case Rep. April 12, 2024;2024(2):23-0122. doi: 10.1530/EDM-23-0122. PMID:
38614119; PMCID: PMC11046340.
- PASCHOU SA, BLETSA E, SALTIKI K, KAZAKOU P, KANTREVA K, KATSAOUNOU P, ROVINA N, TRAKADA G, BAKAKOS P, VLACHOPOULOS CV, PSALTOPOULOU T. Sleep Apnea and Cardiovascular Risk in Patients with Prediabetes and Type 2 Diabetes. Nutrients. Nov. 24, 2022;14(23):4989. doi: 10.3390/nu14234989. PMID: 36501019; PMCID:
PMC9741445.
- KANI ER, KARAVITI E, KARAVITI D, GERONTITI E, PASCHOU IA, SALTIKI K,
STEFANAKI K, PSALTOPOULOU T, PASCHOU SA.
Pathophysiology, diagnosis, and management of diabetes mellitus induced by immune checkpoint inhibitors. Endocrine. September 24, 2024. doi: 10.1007/s12020-024-04050-5. Published online ahead of print. PMID:
39316333.
- KANTREVA K, KATSAOUNOU P, SALTIKI K, TRAKADA G, NTALI G, STRATIGOU T, TZANELA M, PSALTOPOULOU T, PASCHOU SA. The potential effect of the antidiabetic agents GLP-1RA and SGLT-2i on respiratory function. Endocrine. September 17, 2024.
doi: 10.1007/s12020-024-04033-6. Published online ahead of print. PMID: 39289244.
- ARMENI AK, MARKANTES GK, STATHOPOULOU A, SALTIKI K, ZAMPAKIS P,
ASSIMAKOPOULOS SF, MICHALAKI MA. Thyroid Eye Disease as an Initial Manifestation of Graves’ Disease Following a SARS-CoV-2 Viral Vector Vaccine: A Case Report and
Review of the Literature. Vaccines (Basel). Oct. 10, 2023;11(10):1574. doi:
10.3390/vaccines11101574. PMID: 37896977; PMCID: PMC10611184.
- KATERINA SALTIKI, OLGA KARAPANOU, KANELLA KANTREVA, MARINA MICHALAKI, KONSTANTINOS KOUTSOUKOS, STAVROULA A. PASCHOU, MARIA ALEVIZAKI
Local Treatments and TKI Efficacy in Patients with Radioiodine-Refractory Differentiated Thyroid Carcinoma: A Single-Center Experience
Endocr Relat Cancer. 2022 (under review)
- PARASKEVI KAZAKOU, DIONYSIOS VRACHNIS, STAVROULA A. PASCHOU, KONSTANTINOS NASTOS, HELEN SARLANI, KANELLA KANTREVA, KATERINA STEFANAKI, THEODORA PSALTOPOULOU, GEORGE KYRIAKOPOULOS, PENELOPE KORKOLOPOULOU, KATERINA SALTIKI
An exceptionally rare case of a giant parathyroid adenoma with features of carcinoma
Hormones (under revision)
- ELENI SAZAKLI*, OLGA KARAPANOU*, GERASIMOS SYKIOTIS, KATERINA SALTIKI, AND MARINA MICHALAKI
Exploring Adherence to the 2023 ETA Clinical Practice Guidelines for the Management of Thyroid Nodules with Indeterminate Cytology: A Nationwide Survey
THYROID (submitted)
